Abstract
This chapter surveys the neurotransmitters and their receptors within the neostriatum (caudate-putamen, NS), globus pallidus (GP) and substantia nigra (SN), but is deliberately biased towards those transmitters involved in the principal input and output pathways of the basal ganglia in an attempt to relate neuronal circuitry to function. Where appropriate, behavioural data have also been presented and reference has been made to the abnormal movement disorders affecting basal ganglia function. Morphological evidence for the relevant pathways and connections can be found elsewhere within this volume. No attempt has been made to consider the peptide transmitters, neurotensin, somatostatin, TRH, angiotensin, cholecystokinin and the opiates, which are found in the basal ganglia, but whose involvement in motor function has not been well established. Whereas species differences may be of considerable importance in any anatomical review, there is insufficient evidence pertaining to the variation across species of pharmacological and neurochemical data, and thus attempts have generally not been made to nominate the animal species employed. The present article will not discuss the ventral striatum (nucleus accumbens septi), whose connections are less well defined, but these have been dealt with elsewhere (Fonnum and Walaas, 1979; Heimer and Van Hoesen, 1979).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Afifi, A. K. A., Bahuth, N. B., Kaelber, W. W., Michael, E., and Nassar, S., 1974, The corticonigral fibre tract. An experimental Fink-Heimer study in cats, J. Anat., 118:469.
Aghajanian, G. K., and Bunney, B. S., 1973, Central dopaminergicneurons: Neurophysiological identification and responses to drugs, in: “Frontiers in Catecholamine Research,” S. H. Snyder and E. Usdin, eds., Pergamon Press, New York.
Alloway, K. D., and Rebec, G. V., 1983, Shift from inhibition to excitation in the neostriatum but not in the nucleus accumbens following long-term amphetamine. Brain Res., 273:71.
Anden, N. E., Golembiowsak-Nikitin, K., and Thornstrom, U., 1982, Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933 respectiovely, Naunyn-Schmiedeberg’s Arch. Pharmacol., 321:100.
Anderson, M. E., and Yoshida, M., 1980, Axonal branching patterns and location of nigrothalamic and nigrocollicular neurones in the cat, J. Neurophysiol., 43:883.
Andrews, P. R., and Johnston, G. A., 1979, GABA agonists and antagonists, Biochem. Pharmaco1., 28:2967.
Asper, H., Baggiolini, M., Burki, H. R., Laeuner, H. and Stille, G., 1973, Tolerance phenomena with neuroleptics, catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol, Eur. J. Pharmacol., 22:287.
Azmitia, E. C., 1978, The serotonin-producing neurones of the midbrain median and dorsal raphe nuclei, in: “Handbook of Psychopharmacology ,” L. L. Iversen, S. D. Iversen and S. H. Snyder, eds.. Plenum Press, New York.
Bartholini, G., 1980, Interaction of striatal dopaminergic, cholinergic, and GABAergic neurons: relation to extrapyramidal function. Trends Pharmacol. Sci., 1:138.
Bartus, R. T., Dean, R. L., Beer, B., and Lippa, A. S., 1982, The cholinergic hypothesis of geriatric memory dysfunction. Science, 217:408.
Beart, P. M., 1982, Multiple dopamine receptors — new vistas. Trends Pharmacol. Sci., 3:100.
Beaujouan, J. Torrens, Herbet, A., Daguet, M. C., Glowinski, J., and Prochiantz, A., 1982, Specific binding of an immunoreactive and biologically active 1251-labelled substance P derivative to mouse mesencephalic cells in culture, Mol Pharmacol., 22:48.
Beckstead, R. M., 1979, An autoradiographic examination of corticortical and subcortical projections of the mediodorsal-projection (prefrontal) cortex in the rat, J. Comp. Neurol., 184:43.
Beckstead, R. M., Domesick, V. M., and Nauta, W. J. H., 1979, Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res., 175:191.
Besson, M. J., Keriel, M. L., Gauchy, C., and Glowinski, J., 1982, Bilateral asymmetrical changes in the nigral release of [3H] GABA induced by unilateral application of acetylcholine in the cat caudate nucleus. Brain Res., 241:241.
Bird, E. D., and Iversen, L. L., 1974, Huntington’s chorea- post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase in basal ganglia. Brain, 97:457.
Bjorkltind, A., and Lindvall, O., 1975, Dopamine in dendrites of substantia nigra neurones: suggestions for a role in dendritic terminals. Brain Res., 83:531.
Bowery, N. G., 1982, Baclofen: 10 years on. Trends Pharmacol. Sci., 3:400.
Bowery, N. G., Hill, D. R., and Hudson, A. L., 1982, Guanylnucleotides decrease the binding affinity of GABA-B receptors in the mammalian C.N.S., Br. J. Pharmacol., 75:86P.
Bowery, N. G., Hill, D. R., Hudson, A. L., Doble, A., Middlemiss, D. N., Shaw, J., and Turnbull, M., 1980, (-) Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature, 283:92.
Brownstein, M. J., Mroz, E. A., Tappaz, M. L., and Leeman, S., 1977, On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra. Brain Res., 135:315.
Cannon, J. G., 1983, Structure-activity relationships of dopamine agonists, Ann. Rev. Pharmacol. Toxicol., 23:103
Carlsson, A., 1977, Dopamine autoreceptors: background and implications. Adv. Biochem. Psychopharmacol., 16:439.
Carter, J., 1980, Evidence for glutamatergic projections from the prefrontal cortex to the striatum, nucleus accumbens, amygdaloid complex and substantia nigra in the rat, Neurosci. Letts., Supplement 5:580.
Carter, C. J., and Pycock, J., 1981, The role of 5-hydroxytryptamine in dopamine-dependent stereotyped behaviour. Neuropharmacology, 20:261.
Chase, T. N., 1974, Serotonergic-dopaminergic interactions and extrapyramidal function. Adv. Biochem, Psychopharmacol., 11:377.
Cheramy, A., Chesselet, M. F., Romo, R., Leviel, V., and Glowinski, J., 1983, Effects of vinilateral electrical stimulation of various thalamic nuclei on the release of dopamine from dendrites and nerve terminals of neurons of the two nigrostriatal dopaminergic pathways, Neurosci., 8:767.
Cheramy, A., Leviel, V., and Glowinski, J., 1981, Dendritic release of dopamine in the substantia nigra. Nature, 289:537.
Cheramy, A., Nieoullon, A., and Glowinski, J., 1978a, GABAergicprocesses involkved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat, Eur. J. Pharmacol., 48:281.
Cheramy, A., Nieoullon, A., and Glowinski, J., 1978b, Effects of unilateral nigral application of baclofen on dopamine release in the two caudate nuclei of the cat, Eur. J. Pharmacol, 58:133.
Cheramy, A., Nieoullen, A., Michelot, R., and Glowinski, J., 1977, Effects of intranigral applications of dopamine and substance P on the in vivo release of newly synthesized 3H-dopamine in the ipsilateral caudate nucleus of the cat, Neurosci. Letts., 4:105.
Childs, J. A., and Gale, K., 1983, Neurochemical evidence for a nigrotegmental GABAergic projection. Brain Res., 258:109.
Cools, A. R., 1982, The puzzling ‘cascade’ of multiple receptors for dopamine. Trends Pharmacol. Sci., 2:178.
Corsini, G. U., Pitzalis, G. F., Bernardi, F., Bochetta, A., and Del Zompo, M., 1981, The use of dopamine agonists in the treatment schizophrenia. Neuropharmacology, 20:1309.
Costa, E., Cheney, D. L., Mao, C. C., and Moroni, F., 1978, Action of antischizophrenic drugs on the metabolism of gamma-aminobutyric acid and acetylcholine in globus pallidus, striatum and n. accumbens. Fed. Proc., 37:2408.
Costall, B., Naylor, R. J., and Owen, R. T., 1978, GABAminergic and serotonergic modulation of the antidyskinetic effects of tiapride and oxiperomide in the model using 2-(N,N-dipropyl)- amino-5,6-dihydroxy tetralin, Eur. J. Pharmacol., 49:407.
Coyle, J. T., Bird, S. J., Evans, R. H., Gulley, R. L., Nadler, J. v., Nicklas, W. J., and Olney, J. W., 1981, Excitatory amino acid neurotoxins: selectivity, specificity and mechanisms of action, Neurosci. Res. Program Bull., 19:1.
Creese, I., Sibley, D. R., Hamblin, M. W., and Leff, S. E., 1983, The classification of dopamine receptors: relationship to radioligand binding, Ann. Rev. Neurosci., 6:43.
Cross, A. J., and Owen, F., 1980, Characteristics of 3H-cis-flupenthixol binding to calf brain membranes, Eur. J. Pharmacol., 65:341.
Cross, A J., and Waddington, J. L., 1981, Kainic acid lesions dissociate [3H]cis-flupenthixol binding sites in rat striatum, Eur. J. Pharmacol., 71:327.
Cuello, A. C., and Kanazawa, I., 1978, The distribution of substance P immunoreactive fibres in the rat central nervous system, J. Comp. Neurol., 178:129.
Curtis, D. R., 1981, Problems in the evaluation of glutamate as a central nervous system transmitter, “Glutamic Acid: Advances in Biochemistry and Physiology,” L. J. Filer, S. Garattini, M. R. Kare, W. A. Reynolds, and R. J. Wurtman, eds.. Raven Press, New York.
Curtis, D. R., and Johnston, G. A. R., 1975, Amino acid transmitters in the mammalian central nervous system. Rev. Physiol., 69:97.
Curtis, D. R., Lodge, D., Bornstein, J. C., and Peet, M. J., 1981, Selective effects of (-) baclofen on spinal synaptic transmission in the cat, Exp. Brain Res., 42:158.
Davies, J., anmd Dray, A., 1976, Substance P in the substantia nigra. Brain Res., 107:623.
Davies, P., and Maloney, A. J. F., 1976, Selective loss of central cholinergic neurones in Alzheimer’s disease. Lancet, II:1403.
de Belleroche, J. S., and Bradford, H. F., 1980, Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine and glutamate, J. Neurochem., 35:1227.
de Montis, G. M., Olianas, M. C., Serra, G., Tagliamonte, A., and Scheel-Kruger, J., 1979, Evidence that a nigral GABAergic- cholinergic balance controls posture, Eur. J. Pharmaco1., 53:181.
Deniau, J. M., Hammond, C., Riszk, A., and Feger, J., 1978, Electrophysiological properties of identified output neurons of the rat substantia nigra (pars compacta and pars reticulata): evidences for the existence of branched neurons, Exp. Brain Res., 32:409.
Di Chiara, G., Morelli, M., Porceddu, M. L., and Gessa, G. L., 1978, Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation. Life Sci., 23:2045.
Di Chiara, G., Morelli, M., Porceddu, M. L., and Gessa, G. L., 1979, Role of thalamic gamma-aminobutyrate in motor functions: catalepsy and ipsiversive turning after intrathalamic muscimol, Neurosci., 4:1453.
Di Chiara, G., Porceddu, M. L., Imperato, A., and Morelli, M., 1981, Role of GABA neurons in the expression of striatal motor functions. Adv. Biochem. Psychopharmacol., 30:129.
Divac, I., 1975, Magnocellular nuclei of the basal-forebrain project to neocortex, brainstem, and olfactory bulb. Review of some functional correlates. Brain Res., 93:385.
Divac, I., Fonnum, F., and Storm-Mathisen, J., 1977, High affinity uptake of glutamate in terminals of corticostriatal axons. Nature, 266:377.
Dray, A., 1979, The striatum and substantia nigra: A commentary on their relationships, Neurosci., 4:1407.
Dray, A., 1980, The physiology and pharmacology of mammalian basal ganglia. Prog. Neurobiol., 14:221.
Dray, A., Gonye, T. J., Oakley, N. R., and Tanner, T., 1976, Evidence for the existence of a raphe projection to the substantia nigra in rat. Brain Res, 113:45.
Dray, A., and Oakley, N. R., 1978, Projections from nucleus accumbens to globus pallidus and substantia nigra in the rat, Experientia, 34:68.
Enna, S. J., Bird, E. D., and Bennett, J. P., Jr., 1976, Huntington’s chorea. Changes in neurotransmitter receptors in the brain, N. Engl. J. Med., 294:1305.
Enna, S. J. and Gallagher, J. P., 1983, Biochemical and electrophysiological characteristics of mammalian GABA receptors. Int. Rev. Neurobiol., 24:181.
Ennis, C., Kemp, J. D., Cox, B., 1981, Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum, J. Neurochem., 36:1515.
Erspamer, G. F., Erspamer, V., and Piccinnelli, D., 1980, Parallel bio-assay of physalaemin and kassinin, a tachykinin dodecapeptide from the skin of the African frog kassina senegalensis, Natmyn Schmiedeberg’s Arch. Pharmacol., 311:61.
Euvrard, C., Javoy, F., Herbet, A., and Glowinski, J., 1977, Effect of quipazine, a serotinin-like drug, on striatal cholinergic interneurones, Eur. J. Pharmacol., 41:281.
Fahn, S., 1976, Regional distribution studies of GABA and other putative neurotransmitters and their enzymes, in: “GABA in Nervous System Ftmction,” E. Roberts, T. N. Chase, and D. B. Tower, esq.. Raven Press, New York.
Fibiger, H. C., and Miller, J. J., 1977, An anatomical and electrophysiological investigation of the serotoninergic projection from the dorsal raphe nucleus to the substantia nigra in the rat, Neuroscience, 2:975.
Fonnum, F., Gottesfeld, Z., and Grofova, I., 1978, Distribution of glutamate decarboxylase, choline aeetyltransferase and aromatic acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres. Brain Res., 143:125.
Fonnum, F., and Walaas, I., 1979, Localization of neurotransmitter candidates in the neostriatum, in: “The Neostriatum,” I. Divac. and R. G. E. Oberg, eds., Pergamon Press, Sydney.
Fozard, J. R., 1983, Functional correlates of 5-HTl recognition sites. Trends Pharmacol. Sci., 4:288.
Gale, K., 1981, Relationship between the presence of dopaminergic neurons and GABA receptors in substantia nigra: effects of lesions. Brain Res., 210:410.
Gale, K., 1982, Evidence for GABA receptors on serotonergic afferent terminals in the substantia nigra and on nigral efferent projections to the caudal mesencephalon. Brain Res., 231:209.
Garau, L., Govoni, S., Stefanini, E., Trabucchi, M., and Spano, P. F., 1978, Dopamine receptors: pharmacological and anatomical evidence indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci., 23:1745.
Garcia-Munoz, M., Nicolaou, N. M., Tulloch, I F., Wright, A. K., and Arbuthnott, G. W., 1977, Feedback loop or output pathway in striatonigral fibres. Nature, 265:363.
Garcia-Mtinoz, M., Patino, P., Wright, A. J., and Arbuthnott, G. W., 1983, The anatomical substrate of the turning behaviour seen after lesions in the nigrostriatal dopamine system, Neuroscience, 8:87.
Geyer, M. A., Puerto, A., Dawsey, W. J., Knappi, S., Bullard, W. P., and Mandell, A. J., 1976a, Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways. Brain Res., 106:241.
Geyer, M. A., Puerto, A., Menkes, D. B., Segal, D. S., and Mandell, A. J., 1976b, Behavioural studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Res., 106:257.
Giorguieff, M. F., Kemel, M. L., and Glowinski, J., 1977, Presynaptic effects of L-glutamic acid on the release of dopamine in rat striatal slices, Neurosci. Letts., 6:73.
Godukhin, O. V., Zharikova, A. D., and Novoselor, V. I., 1980, The release of labelled L-glutamic acid from rat neostriatum in vivo following stimulation of frontal cortex, Neuroscience, 5:2151.
Goodale, D. B., Rusterholz, D. B., Long, J. P., Flynn, J. R., Walsh, B, Cannon, J. G., and Lee, T., 1980, Neurochemical and behavioural evidence for a selective presynaptic dopamine receptor agonist. Science, 210:1141.
Gothert, M., and Schlicker, E., 1983, Autoreceptor-mediatedinhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine, Life Sci., 32:1183.
Gottfries, C. G., Adlfson, R., Aquilonius, S. M., Carlsson, A., Oreland, L., Svennerholm, L., and Winblad, B., 1980, Parkinsonism and dementia disorders of Alzheimer type: Similarities and differences in Parkinson’s disease, in: “Current Progress, Problems and Management,” U. K. Rinne, M. Klinger, and G. Stamm, eds., Elsevier, Amsterdam.
Grace, A. A., and Bnney, B. S., 1979, Paradoxical GABA excitation of nigral dopaminergic cells, indirect mediation through reticulata inhibitory neurons, Eur. J. Pharmaco1., 59:211.
Groves, P. M., 1983, A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Res., 286:109.
Groves, P. M., Wilson, C. J., Yotmg, S. J., and Rebec, G. V., Self-inhibition by dopaminergic neurons. Science, 190:522.
Gulley, R. L., and Smithberg, M., 1971, Synapses in the cat substantia nigra. Tissue Cell, 3:691.
Gundlach, A. L., Krstich, M., and Beart, P. M., 1983, Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates. Brain Res., 278:155.
Guyenet, P. G., Agid, Y., Javoy, F., Beaujouan, J C., Boissier, J., and Glowinski, J., 1975, Effects of dopaminergic receptor agonists and antagonists on the affinity of the neostriatal cholinergic system. Brain Res, 84:277.
Guyenet, P. G., and Aghajanian, G. K., 1979, Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra. Brain Res., 150:69.
Hahn, R. A., Wardell, J. R., Sarau, H. M., and Ridley, P. T., 1982, Characterisation of the peripheral and central effects of SK- and F-82526, a novel dopamine receptor agonist, J. Pharmacol. Exp. Ther., 223:305.
Hall, M. D., Jenner, P., Kelly, E., and Marsden, C. D., 1983, Differential anatomical location of [3H]-spiperone binding sites in the striatum and substantia nigra of the rat, Brit. J. Pharmacol., 79:599.
Hamon, M., Nelson, D. L., Herbert, A., and Glowinski, J., 1980, Multiple receptors for serotonin in the rat brain, in: “Receptors for Neurotransmitters and Peptide Hormones,” G. Pepeu, M. J. Kuhar, and S. J. Enna, eds.. Raven Press, New York.
Hanley, M. R., Sandberg, B. E. B., Lee, C. M., Iversen, L. L., Brtindish, D. E., and Wade, R., 1980, Specific binding of 3H-substance P to rat brain membranes. Nature, 286:810.
Hedreen, J. C., 1977, Corticostriatal cells identified by the peroxidase method, Neurosci. Letts., 4:1.
Heimer, L., and van Hoesen, G., 1979, Ventral striatum, m: “The Neostriatum.” I. Divac and R. G. E. Oberg, eds., Pergamon Press, Sydney.
Helmeste, D. M., and Seeman, P., 1982, Amphetamine-induced hypolocomotion in mice with more brain D2 dopamine receptors. Psychiatry Res., 7:351.
Herkenham, M., 1979, The afferent and efferent connections of the ventromedial thalamic nucleus in the rat, J. Comp. Neurol., 183:679.
Hery, F., Soubrie, P., Bourgoin, S., Motastruc, J. L., Artaud, F., and Glowinski, J., 1980, Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin. Brain Res., 193:143.
Hill, D. R., and Bowery, N. G., 1981, 3H-Baclofen and 3H-GABA bind to bicuculline-insensitive GABA-B sites in rat brain. Nature, 290:149.
Hjorth, S., Carlsson, A., Wikstrom, H., Lindberg, P., Sanchez, D., Hacksell, U., Arvidsson, L. -E., Svensson, U., and Nilsson, J. L. G., 1981, 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sci., 28:1225.
Hornykiewicz, O., 1979, Brain dopamine in Parkinson’s disease and other neurological disturbances, in: “The Neurobiology of Dopamine,” A. S. Horn, J. Korf and B. H. C. Westerink, eds.. Academic Press, London.
Hyttel, J., 1980, Further evidence that 3H-cis(Z)flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum, Psychopharmacology (Berlin), 67:107.
Hyttel, J., 1983, SCH 23390 — The first slective dopamine D-1 antagonist, Eur. J. Pharmacol., 91:153.
Iversen, L. L., 1982, Substance P., Br. Med. Bull., 38:277.
Iversen, L. L., Lee, C. M., Gilbert, R. F., Hunt, S., and Emson, P. C., 1980, Regulation of neuropeptide release, Proc. R. Soc. Lond. [Biol]., 210:91.
Iversen, L. L., Rogawski, M. A., and Miller, R. J., 1976, Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. Mo1. Pharmaco1., 12:251.
Jacobs, B. L., 1976, An animal behaviour model for studying central serotonergic synapses. Life Sci., 19:777.
James, T. A., and Starr, M. S., 1977, Behavioural and biochemical effects of substance P injected into the substantia nigra of the rat, J. Pharm. Pharmacol., 29:181.
James, T. A., and Starr, M. S., 1978, The role of GABA in the substantia nigra. Nature, 275:229.
James, T. A., and Starr, M. S., 1980, Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum, J. Pharm. Pharmacol., 32:196.
Jessell, T. M., 1978, Substance P release from the rat substantia nigra. Brain Res., 151:469.
Jessell, T. M., Emson, P. C., Paxinos, G., and Cuello, A. C., 1978, Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study. Brain Res., 152:487.
Johnston, G. A. R., 1979, Central nervous system receptors for glutamic acid, in: “Glutamic Acid: Advances in Biochemistry and Physiology,” L. J. Filer. Jr., ed.. Raven Press, New York.
Johnston, G. A. R., 1981, GABA Receptors, in: “The role of Peptides and Amino Acids as Neurotransmitters,” J. B. Lombardini, ed., Liss Inc., New York.
Johnston, M. V., McKinney, M., and Coyle, J. T., 1979, Evidence for a cholinergic projection to neocortex from neurones in basal forebrain, Proc. Natl. Acad. Sci. (USA), 76:5392.
Jones, D. L., and Mogenson, G. J., 1980, Nucleus accumbens to globus pallidus GABA projection: electrophysiological and iontophoretic investigations. Brain Res., 188:93.
Jones, D. L., Mogenson, G. J., and Wu, M., 1981, Injections of dopaminergic, cholinergic, serotonergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat, Neuropharmacol., 20:29.
Juraska, J. M., Wilson, C. J., and Groves, P. M., 1977, The substantia nigra of the rat: a Golgi study, J. Comp. Neurol., 172:585.
Kanazawa, Bird, E. D. Gale, J. S. Iversen, L. Jessell, T. M. Muramoto, O. Spokes, and Sutoo, D., 1979, Substance P: decrease in substantia nigra and globus pallidus in Hiintington’s disease, “Huntington’s Disease, Advances in Neurology,” Raven Press, New York.
Kanazawa, I., and Yoshida, M., 1980, Electrophysiological evidence for the existence of excitatory fibres in the caudato-nigral pathway in the cat, Neurosci. Letts., 20:301
Karobath, M., Placheta, P., Lippitsch, M., and Krogsgaard-Larsen, P., 1979, Is stimulation of benzodiazepine receptor binding mediated by a novel GABA receptor? Nature, 278:748.
Kebabian, J. W., and Calne, D. B., 1979, Multiple receptors for dopamine. Nature, 277:93.
Kelly, P., and Moore, K. E., 1976, Mesolimbic dopamine neurons in the rotational model of nigrostriatal function. Nature, 263:695.
Kemp, J. M., and Powell, T. P. S., 1971, The site of termination of afferent fibres in the caudate nucleus, Phil. Trans. R. Soc. Lond [Biol.], 262:413.
Kilpatrick, I. C., and Starr, M. S., 1981, Involvement of dopamine in circling responses to muscimol depends on intranigral sites of injection, Eur. J. Pharmacol., 69:407.
Kim, J-S., Hassler, R., Haug, P., and Paik, K. S., 1977, Effect of frontal cortex ablation on striatal glutamic acid level in rat. Brain Res., 132:370.
Kimura, H., McGeer, P. L., Peng, F., and McGeer, E. G., 1980, Choline acetyltransferase-containing neurons in rodent brain demonstrated by immunohistochemistry. Science, 208:1057.
Kobayashi, R. M., Brownstein, M., Saavedra, J. M., and Palkovits, M., 1975, Choline aeetyltransferase content in discrete regions of the brainstem, J. Neurochem., 24:637.
Krogsgaard-Larsen, P., and Honore, T., 1983, Glutamate receptors and new glutamate agonists. Trends Pharmacol. Sci., 4:31.
Langer, S. Z., 1981, Presynaptic regulation of the release of catecholamines, Pharmaco1. Rev., 81:337.
Leander, S., Hakanson, R., Rosell, S., Folkers, K., Sundler, F., and Tornqvist, K., 1981, A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature, 294:467.
Lee, C. M., Iversen, L. L., Hanley, M. R., and Sandberg, B. E., 1982, The possible existence of multiple receptors for substance P, Naunyn Schmeidebergs Arch. Pharmacol., 318:281.
Lee, T., Seeman, P., Rajput, A., Farley, I. J., and Hornykiewicz, O., 1978, Receptor basis for dopaminergic supersensitivity in Parkinson’s disease. Nature, 273,59.
Leff, S., Adams, L., Hyttel, J., and Creese, I., 1981, Kainate lesion dissociates striatal dopamine receptor radioligand binding sites, Eur. J. Pharmacol., 70:71.
Leff, S. E., and Creese, I., 1983, Dopamine receptors re-explained. Trends Pharmacol. Sci., 4:463.
Lehmann, J., Nagy, J. I., Atmadia, S., and Fibiger, H. C., 1980, The nucleus basalis magnocellularis: the origin of a cholinergic projection to the neocortex of the rat, Neurosci., 5:1161.
Lehmann, J., and Scatton, B., 1982, Characterization of the excitatory amino acid receptor-mediated release of [3H]acetylcholine from rat striatal slices. Brain Res., 252:77.
Leysen, J. E., Niemegeers, C. J. E., Van Nueten, J. M., and Laduron, P., 1982, [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin 2 receptor binding sites. Binding properties, brain distribution, and functional role, Mol. Pharmacol., 21:301.
Lindvall, O., and Bjorkltind, A., 1978, Anatomy of the dopaminergic neuron systems in the rat brain. Adv. Biochem. Psychopharmacol., 19:1.
Ljungdahl, A., Hokfelt, T., and Nilsson, G., 1978, Distribution of substance P-like immunoreactivity in the central nervous system of the rat. I. Cell bodies and nerve terminals, Neurosci., 3:861.
Lloyd, K. G., 1980, The neuropathology of GABA neurons in extrapyramidal disorders, J. Neural. Transm. [Suppl.], 16:217.
Lo, M. S. L., Neihoff, D. L., Kxihar, M. J., and Snyder, S. H., 1983, Differential localization of type I and type II benzodiazpeine binding sites in substantia nigra. Nature, 306:57.
Marsden, C. D., 1979, GABA in relation to extrapyramidal diseases, with particular relevance to animal models, “GABA Neurotransmitters,” P. Krogsgaard-Larsen, J. Scheel-Kruger, and H. Kofod, eds., Munksgaard, Copenhagen.
Marshall, J. F., and Ungerstedt, U., 1977, Striatal efferent fibres play a role in maintaining rotational behaviour in the rat. Science, 198:62.
Martin, L. L., and Sanders-Bush, E., 1982, Comparison of the pharmacological characteristics of 5-HTl and 5-HT2 sites with those of serotonin autoreceptors which modulate serotonin release, Naunyn-Schmiedelberg’s Arch. Pharmacol., 321:165.
McGeer, P. L., McGeer, E. G., Scherer, U., and Singh, K., 1977, A glutamatergic corticostriatal tract? Brain Res., 128:369.
McKinney, M., Coyle, J. T., and Hedreen, J. C., 1983, Topographical analysis of the innervation of the rat neocortex and hippocamnpus by the basal forebrain cholinergic system, J. Comp. Neurol., 217:103.
McPherson, G. A., and Beart, P. M., 1983, The selectivity of some ergot derivatives for alphal and alpha 2 adrenoceptors of rat cerebral cortex, Eur. J. Pharmacol., 91:363.
Mefford, I. N., Foutz, A., Noyce, N., Jurik, S. M., Handen, C., Dement, W. C., and Barchas, J. D., 1982, Distribution of norepinephrine, epinephrine, dopamine, serotonin, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindole-3-acetic acid in dog brain. Brain Res., 236:339.
Michelot, R., Leviel, V., Giorguieff-Chesselet, M. F., Cheramy, A., and Glowinski, J., 1979, Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigrostriatal dopaminergic pathways. Life Sci, 24:715.
Miller, J. J., Richardson, T. L., Fibiger, H. C., and McLennan, H., 1975, Anatomical and electrophysiological identification of a projection from the mesencephalic raphe to the caudate-putamen in the rat. Brain Res., 97:133.
Mitchell, R., 1980, A novel GABA receptor modulates stimulus-induced glutamate release from cortico-striatal terminals, Eur. J. Pharmacol., 67:119.
Möhler, H. and Okada, T., 1978, Properties of gamma-aminobutyric acid receptor binding with (+)-[3H]bicuculline methiodide in rat cerebellum. Mol. Pharmacol., 14:256.
Möhler, H., Okada, T., and Enna, S. J., 1978, Benzodiazepine and neurotransmitter receptor binding in rat brain after chronic administration of diazepam or phénobarbital. Brain Res., 156:391.
Moore, R. Y., and Bloom, F. E., 1978, Central catecholamine neuron system: Anatomy and physiology of the dopamine systems, Ann. Rev. Neurosci., 1:29.
Moore, K. E., and Wuerthle, S. M., 1979, Regulation of nigrostriatal and tuberinfundibular-hypophyseal dopaminergic neurons. Prog. Neurobiol., 13:325.
Murrin, L. C., Gale, K., and Kuhar, M. J., 1979, Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions, Eur. J. Pharmacol., 60:229.
Nadler, J. V., Evenson, D. A., and Cuthbertson, G. J., 1981, Comparative toxicity of kainic acid and other acidic amino acids toward rat hippocampal neurons, Neurosci., 6:2505.
Nelson, D. L., Herbet, A., Enjaalbert, A., Bockaert, J., and Hamon, M, 1980, Serotonin-sensitive adenylate cyclase and [H]serotonin binding sites in the central nervous system of the rat, Biochem. Pharmacol., 29:2445.
Neve, K. A., Kozlowski, M. R., and Marshall, J. F., 1982, Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioural supersensitivity. Brain Res., 244:33.
Nicoll, R. A., Alger, B. E., and Jahr, C. E., 1980, Peptides as putative excitatory neurotransmitters: carnosine, enkephalin, substance P and TRH, Proc. R. Soc. Lond. [Biol.], 210:133.
Nilsson, J. L. G., and Carlsson, A., 1982, Dopamine-receptor agonist with apparent selectivity for autoreceptors: a new principle for anti-psychotic action? Trends Pharmacol. Sci., 3:322.
Olianas, M. C., De Montis, G., Mulas, G., and Tagliamonte, A., 1978, The striatal dopaminergic function is mediated by the inhibition of a nigral non-dopaminergic neuronal system via a strio-nigral, GABAergic pathway, Eur. J. Pharmaco1., 49:233.
Olivier, A., Parent, A., Simard, H., and Poirier, L. J., 1970, Cholinesterasic striatopallidal and striatonigral efferents in the cat and monkey. Brain Res., 18:273.
Olpe, H. R., and Koella, W. P., 1977, Rotatory behaviour in rats by intranigral application of substance P and an eleodoisin fragment. Brain Res., 126:576.
Olsen, R. W., Ticku, M. K., Greenlee, D., and Van Ness, P., 1979, GABA receptor and ionophore binding sites: interaction with various drugs,in: “GABA-Neurotransmitters P. Krogsgaard- Larsen, J. Scheel-Kruger, and H. Kofod, eds., Munksgaard, Copenhagen.
Palkovits, M., and Jacobowitz, D. M., 1974, Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. II. Hindbrain (mesencephalon, rhombencephalon), J. Comp. Neurol., 157:29.
Pasik, P., Pasik, T., and Di Figlia, M., 1979, The internal organization of the neostriatum in mammals, in: “The Neostriatum,” I. Divac and R. G. E. Oberg, eds., Pergamon Press, Oxford.
Pedigo, N. W., Yamamura, H. I., and Nelson, D. L., 1981, Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain, J. Neurochem., 36:220.
Peroutka, S. J., Lebovitz, R. M., and Snyder, S. H., 1979, Serotonin receptor binding sites affected differentially by guanine nucleotides, Mol. Pharmacol., 16:700.
Peroutka, S. J., Lebovitz, R. M., and Snyder, S. H., 1981, Two distinct central serotonin receptors with different physiological functions. Science, 212:827.
Porceddu, M. L., Imperato, A., Melis, M. R., and Di Chiara, G., 1983, Role of ventral mesencephalic reticular formation and related noradrenergic and serotonergic bundles in turning behaviour as investigated by means of kainate, 6-hydroxydopamine and 5,7-dihydroxytryptamine, Brain Res., 262:187.
Quik, M., Emson, P. C., and Joyce, E., 1979, Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra. Brain Res., 167:355.
Quirion, R., Shults, C. W., Moody, T. W., Pert, C. B., Chase, T. N., and O’Donohue, T. L., 1983, Autoradiographic distribution of substance P receptors in rat central nervous system. Nature, 303:714.
Reavill, C., Leigh, N., Jenner, P., and Marsden, C. D., 1981, Critical role of midbrain reticular formation in the expression of dopamine-mediated circling behaviour. Adv. Biochem. Psychopharmacol., 30:187.
Reisine, T., Soubrie, P., Artaud, F., and Glowinski, J., 1982, Sensory stimuli differentially affect in vivo nigral and striatal [3H]-serotonin release in the cat, Brain Res., 232:77.
Reubi, J., and Cuenod, M., 1979, Glutamate release in vitro from cortico-striatal terminals. Brain Res., 176:185.
Reubi, J. C., Emson, P. C., Jessell, T. M., and Iversen, L. L., 1978, Effects of GABA, dopamine and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro, Naunyn Schmiedebergs Arch. Pharmacol., 304:271.
Ribak, C. E., 1981, The GABAergic neurons of the extrapyramidal system as revealed by immunoeytoehemistry. Adv. Biochem. Psychopharmacol., 30:23.
Rinvik, E., and Grofova, 1970, Observations on the fine structure of the substantia nigra in the cat, Exp. Brain Res., 11:229.
Roberts, P. J., and Anderson, S. D., 1979, Stimulatory effects of L-glutamate and related amino acids on (3H)-dopamine release from rat striatum: an in vitro model for glutamate actions, J. Neurochem., 32:1539.
Roberts, P. J., McBean, G. J., Sharif, N. A., and Thomas, E. M., 1982, Striatal glutamatergic function: modifications following specific lesions. Brain Res., 235:83.
Roberts, P. J., and Sharif, N. A., 1978, Effects of L-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices. Brain Res., 157:391.
Rouzaire-Dubois, B., Hammond, C., Hamon, B., and Feger, J., 1980, Pharmacological blockade of the globus pallidus-induced inhibitory response of subthalamic cells in the rat. Brain Res., 200:321.
Rowlands, G. J., and Roberts, P. J., 1980, Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro, Eur. J. Pharmaco1., 62:241.
Scally, M. C., Ulus, I. H., Wurtman, R. J., and Pettibone, D. J., 1978, Regional distribution of neurotransmitter-synthesizing enzymes and substance P within the rat corpus striatum. Brain Res., 143:556.
Scatton, B., 1982, Further evidence for the involvement of D2, butnot DI dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life Sci., 31:2883.
Scatton, B., and Bartholini, G., 1980, Increase in striatalacetylcholine levels by GABAergic agents: dependence on corticostriatal neurons. Brain Res., 200:174.
Scatton, B., and Lehmann, J., 1982, N-methy1-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids. Nature, 297:422.
Schachter, M., Bedard, P., Debono, A. G., Jenner, P., Marsden, C. D., Price, P., Parkes, J. D., Keenan, J., Smith, B., Rosenthaler, J., Horowki, R., and Dorow, R., 1980, The role of D-1 and D-2 receptors. Nature, 286:157.
Scheel-Kruger, J., Arnt, J., Braestrup, C., Christensen, A. V., Cools, A. R., and MageItind, G., 1978, GABA-dopamine interaction in substantia nigra and nucleus accumbens — relevance to behavioural stimulation and stereotyped behaviour. Adv. Biochem. Psychopharmacol., 19:343.
Scheel-Kruger, J., Magelund, G., and Olianas, M. C., 1981, Role of GABA in striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra, and nucleus subthalamicus. Adv. Biochem. Psychopharmacol., 30:165.
Schultzberg, M., Hokfelt, and Lundberg, J. M., 1982, Coexistence of classical transmitters and peptides in the central and peripheral nervous systems, Br. Med. Bull., 38:309.
Schwarcz, R., Bennett, J. P. Jr., Coyle, J. T. Jr., 1977, Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington’s Disease, J. Neurochem., 28:867.
Schwarcz, R., and Coyle, J. T., 1977, Striatal lesions with kainic acid: neurochemical characteristics. Brain Res., 127:235.
Schwarcz, R., Creese, I., Coyle, J. T., and Snyder, S. H., 1978, Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature, 271:766.
Sethy, V. H., 1979, Regulation of striatal acetylcholine concentration by D2-dopamine receptors, Eur. J. Pharmaco1., 60:397.
Setler, P. E., Sarau, H. M., Sirkle, C. L., and Saunders, H. L., 1978, The central effects of a novel dopamine agonist, Eur. J. Pharmacol., 50:419.
Seyfried, C. A., and Fuxe, K., 1982, Neuropharmacological and neurochemical effects of 3-(4-phenyl-l,2,3,6-tetra hydropyridyl-l)-butyl) indole (EMD 23 498) a new, long-acting dopamine agonist, Arzneim, Forsch., 32:892.
Simke, J. P., and Saelens, J. K., 1977, Evidence for a cholinergic fibre tract connecting the thalamus with the head of the striatum of the rat. Brain Res., 126:487.
Skerritt, J. H., Trisdikoon, P., and Johnston, G. A. R., 1981, Increased GABA binding in mouse brain following acute swim stress. Brain Res., 215:398.
Skirboll, L. R., Grace, A. A., and Bunney, B. S., 1979, Dopamine auto- and post-synaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists. Science, 206:80.
Skolnick, P., Paul, S. M., and Barker, J. L., 1980, Pentobarbital potentiates GABA-enhanced [3H]diazepam binding to benzodiazepine receptors, Eur. J. Pharmacol., 65:125.
Sokoloff, P., Martres, M. -P., and Schwartz, J. C., 1980, Three classes of dopamine rceptors (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-dompepridone, Naunyn Schmiedeberg’s Arch. Pharmacol., 325:89.
Soubrie, P., Montsatruc, J. L., Bourgoin, S., Reisine, Artaud. F., and Glowinski, J., 1981, In vivo evidence for GABAergic control of serotonin release in the cat substantia nigra, Eur, J, Pharmacol., 69:483
Spano, P. F. Memo, M. Stefanini, E. Fresia, Trabucchi, M, 1978, Detection of multiple receptors for dopamine, in: “Receptors for Neurotransmitters and Peptide Hormines, G. Pepeu, M. J. Kuhar, and S. J. Enna, eds,. Raven Press, New York
Spencer, H. J,, 1976, Antagonism of cortical excitation of striatal neurones by glutamic acid diethyl ester: Evidence for glutamic acid as an excitatory transmitter in the rat striatum. Brain Res,, 102:91
Spillane, J,, White, P,, Goodhart, M,, Flack, R,, Bowe, D. M,, and Davison, A,, 1977, Selective vulnerability of neurons in organic dementia. Nature, 266:558
Stadler, H,, Lloyd, K. G,, and Gadea-Ciria, M,, 1973, Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res,, 55:476
Standefer, M. J,, and Dill, R. E,, 1977, The role of GABA in dyskinesias induced by chemical stimulation of the striatum. Life Sci,, 21:1515
Starr, M. S,, 1978, GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum, Eur, J, Pharmacol,, 48:325
Starr, M. C,, Suxmnerhayes, M,, and Kilpatrick, I. C,, 1983, Interactions between dopamine and gamma-aminobutyrate in the substantia nigra: implications for the striatonigral output hypothesis, Neurosci., 8:547.
Strombom, U,, 1976, Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain, Naxmyn Schmeideberg’s Arch, Pharmacol,, 292:167
Tamminga, C. A,, Schaffer, M. H,, Smith, R. C,, and Davies, J. M,, 1973, Schizophrenic symptoms improve with apomorphine. Science, 200:567
Tarsy, D,, Pycock, C. J,, Meldrum, B. S., and Marsden, C. D,, 1978, Focal contralateral myoclonus produced by inhibition of GABA action in the caudate nucleus of rats. Brain, 101:143
Ternaux, J. P,,, Hery, F,, Bourgoin, S,, Adrien, J,, Glowinski, J,, and Hamon, M,, 1977, The topographic distribution of serotonergic terminals in the neostriatum of the rat and the caudate nucleus of the cat. Brain Res,, 121:311
Torrens, Y,, Beaujouan, J. C,, Besson, M. J,, Michelot, R,, and Glowinski, J,, 1981, Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of substance P in the substantia nigra slices of the rat, Eur, J, Pharmacol,, 71:383
Unnerstall, J. R,, and Wamsley, J. K,, 1982, Autoradiographic localization of high-affinity [3H] kainic acid binding sites in the rat forebrain, Eur, J, Pharmacol,, 86:361
Van der Kooy, D., and Hattori, T., 1980, Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labelling study in the rat. Brain Res., 186:1.
Vizi, E. S., Harsing, L. G., and Zsilla, G., 1981, Evidence of the modulatory role of serotonin in acetylcholine release from striatal interneurones. Brain Res., 212:89.
Wachtel, H., Ahlenius, S., and Anden, N. E., 1979, Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following alpha-methyltyrosine or reserpine, Psycho-Pharmacol., 63:203.
Waddington, J. L. and Cross, A. J., 1978, Denervation supersensitivity in the striatonigral GABA pathway. Nature, 276:618.
Waddington, J. L. and Cross, A. J., 1979, Baclofen and muscimol: behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor binding, Naunyn Schmiedebergs Arch. Pharmacol., 306:275.
Walaas, I., 1981, Biochemical evidence for overlapping neocortical and allocortical glutamate projections to the nucleus accumbens and rostral caudate-putamen in the rat brain, Neuroscience, 6:309.
Walters, J. R., and Roth, R. H., 1976, Dopaminergic neuron: An in vivo system for measuring drug interactions with presynaptic receptors, Naunyn Schmiedeberg’s Arch. Pharmacol., 296:5.
Waszczak, B. L., Eng, N., and Walters, J. R., 1980, Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons. Brain Res., 188:185.
Waszczak, B. L., and Walters, J. R., 1983, Dopamine modulation of the effects of gaimna-aminobutyric acid on substantia nigra pars reticulata neurones. Science, 220:218.
Watkins, J. C., 1981, Pharmacology of excitatory amino acid receptors, in: “Glutamate: Transmitter in the Central Nervous System,” P. J. Roberts, J. Storm-Mathisen, and G. A. R. Johnston, eds., John Wiley and Sons, Chichester.
Webster, K. E., 1961. Cortico-striate interrelations in the albino rat, J. Anat. 95:532.
Westfall, T. C., Grant, H., and Perry, H., 1983, Release of dopamine and 5-hydroxytryptamine from striatal slices following activation of nicotinic cholinergic receptors. Gen. Pharmacol., 14:321.
Westfall, T. C., 1974, Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices. Neuropharmacology, 13:693.
Whitehouse, P. J., Price, D. L., Struble, R. G., Clarke, A., Coyle, J. T., and DeLong, M. R., 1982, Alzheimer’s disease: a loss of neurons in the basal forebrain. Science, 215:1237.
Williams, M., and Totaro, J. A., 1982, Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes, Eur. J. Pharmacol., 86:39.
Wilson, C. J., and Groves, P. M., 1980, Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular injections of horseradish peroxidase, J. Comp. Neurol., 194:599.
Wilson, C. J., and Groves, P. M., 1981, Spontaneous firing patterns of identified spiny neurones in the rat neostriatum. Brain Res., 220:67.
Wilson, C. J., Groves, P. M., and Fifkova, E., 1977, Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra, Exp. Brain Res., 30:161.
Wood, P. L., Moroni, F., Cheney, D. L., and Costa, E., 1979, Cortical lesions modulate rates of acetylcholine and gamma-aminobutyric acid, Neurosci. Letts., 12:349.
Wood, P. L., and Richard, J., 1982, GABAergic regulation of the substantia innominata-cortical cholinergic pathway, Neuropharmacol., 21:969.
Yamamura, H. I., and Snyder, S. H., 1974, Muscarinic cholinergic binding in rat brain, Proc. Natl. Acad. Sci., U.S.A., 71:1725.
York, D. H., 1979, The neurophysiology of dopamine receptors, in: “The Neurobiology of Dopamine,” A. S. Horn, J. Korf, and B. H. C. Westerink, eds.. Academic Press, London.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Beart, P.M. (1984). Transmitters and Receptors in the Basal Ganglia. In: McKenzie, J.S., Kemm, R.E., Wilcock, L.N. (eds) The Basal Ganglia. Advances in Behavioral Biology, vol 27. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1212-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1212-3_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1214-7
Online ISBN: 978-1-4684-1212-3
eBook Packages: Springer Book Archive